ESLA
Estrella Immunopharma Inc.
0.471$
-0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | +102.9% | -55.4% | -29.5% | +1.2% | |
| – | – | -98.9% | +8,396.0% | -63.2% | +2.2% | |
| – | – | -99.0% | +10,108.9% | -78.0% | +51.0% | |
| – | – | -99.0% | – | – | +51.0% | |
| – | – | – | – | – | – | |
| – | – | -51.1% | -93.8% | +1,558.6% | +351.9% | |
| – | – | +13.4% | -83.2% | +1,558.6% | +351.9% | |
| – | – | – | – | – | – | |
| – | – | -95.0% | -100.0% | – | +619.8% | |
| – | – | – | -39.6% | -96.6% | -7,312.1% | |
| – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +3.1% | +1.1% | +0.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.